Hope Discovered Here®

Creating a world without heart and vascular disease

We are the Minneapolis Heart Institute Foundation® (MHIF).

For more than 37 years, we’ve been a world-class cardiovascular research and education organization committed to making the impossible possible for our patients.

Patients are at the heart of our mission. We provide:

•Hope for patients, improving their well-being and life expectancy

•Hope for their children, siblings, parents and families

•Hope for new treatment options

•Hope for a world without heart and vascular disease

Learn More
Explore Our Centers

 

Center for Coronary Artery Disease

Valve Science Center

Penny Anderson Women’s Cardiovascular Center

Nolan Family Center for Cardiovascular Health

MHIF Physician-Initiated Research

Global Outreach

Benefits of Participating in Research

Every year, exciting breakthroughs and new discoveries stem from our research. These important findings advance medical knowledge, improving the health and lives of millions of people worldwide.

 

Be More Active

Take a more active role in your own health care.

Potential to Unlock More Options

You may gain access to investigational treatments and medications.

Make a Contribution

Help find new and better ways to treat people with your condition.

Find Clinical Research Trials

 

Our clinical research studies test new drugs, devices and medical procedures to improve care for future generations. View current research studies and see if you qualify to participate.

Read Our Latest News

Dr. Vinayak Bapat Joins MHIF’s Valve Science Center Research Team

Dr. Vinayak Bapat Joins MHIF’s Valve Science Center Research Team

Vinayak (Vinnie) Bapat, MD, is joining the Valve Science Center team, bringing his extensive expertise as a cardiothoracic surgeon and innovator in treatment of heart valve disease. He will also be working directly with patients as a cardiothoracic surgeon at the Minneapolis Heart Institute®.

Minneapolis Heart Institute Foundation and UC-San Diego Receive FDA Approval of Investigational New Drug Application to Continue Research of Novel Hydrogel for Cardiac Tissue Repair

Minneapolis Heart Institute Foundation and UC-San Diego Receive FDA Approval of Investigational New Drug Application to Continue Research of Novel Hydrogel for Cardiac Tissue Repair

MHIF is conducting additional research on a novel hydrogel that is designed to repair cardiac tissue. In April 2020, the FDA approved an Investigational New Drug (IND) application to investigate the safety and feasibility of delivering VentriGel via catheter into areas of the heart of patients that cannot be completely revascularized at the time of coronary artery bypass grafting (CABG).

Join Us at Upcoming Events

Valentine’s Day TC 5K 2019

Valentine’s Day TC 5K 2019

MHIF is proud to be the presenting sponsor for Twin Cities in Motion’s Valentine’s Day TC 5K again this year! Walk or run with us on February 9, 2019! This year’s race will help raise awareness for women’s heart health research.

2018 Heartbeat Gala

2018 Heartbeat Gala

The 2018 MHIF Heartbeat Gala was an incredible evening celebrating innovation. We hope you were inspired to find and embrace your adventure! A huge thank you to our sponsors for the evening. Thanks also to everyone who generously gave through...

Research Intern Poster Reception 2018

Research Intern Poster Reception 2018

2018 Research Intern Poster Reception   What independent research questions are inspiring our cardiovascular physicians? How are physicians and research staff developing the next generation of researchers? Join Minneapolis Heart Institute Foundation®...

Sign up For Our Newsletter

Stay up to date on MHIF news, events and the latest information on heart disease treatment and prevention.